EFFICACY AND SAFETY OF CRISABOROLE IN PATIENTS ≥3 MONTHS OF AGE WITH MILD-TO-MODERATE ATOPIC DERMATITIS (AD)

被引：0

作者：

Su, John C. ^{[1
]}

Spelman, Lynda J. ^{[2
]}

Eichenfield, Lawrence F. ^{[3
,4
]}

Gold, Linda F. Stein ^{[5
]}

Cha, Amy ^{[6
]}

Graham, Daniela ^{[7
]}

Takiya, Liza ^{[8
]}

Werth, John L. ^{[9
]}

Zang, Chuanbo ^{[10
]}

Vlahos, Bonnie ^{[11
]}

机构：

[1] Univ Melbourne, Murdoch Childrens Res Inst, Melbourne, Vic, Australia

[2] Verac Clin Res, Brisbane, Qld, Australia

[3] Univ Calif San Diego, Rady Childrens Hosp San Diego, Pediat & Adolescent Dermatol, San Diego, CA USA

[4] Univ Calif San Diego, Dept Dermatol & Pediat, San Diego, CA USA

[5] Henry Ford Hlth Syst, Dept Dermatol, Detroit, MI USA

[6] Pfizer Inc, Global Med Affairs Inflammat & Immunol, New York, NY USA

[7] Pfizer Inc, Hlth Econ & Outcomes Res Patient & Hlth Impact In, Collegeville, PA USA

[8] Pfizer Inc, North Amer Med Affairs Inflammat & Immunol, Collegeville, PA USA

[9] Pfizer Inc, Clin Dev & Operat, Collegeville, PA USA

[10] Pfizer Inc, Biostat, Collegeville, PA USA

[11] Pfizer Inc, Global Prod Dev Inflammat & Immunol, Collegeville, PA USA

来源：

ACTA DERMATO-VENEREOLOGICA | 2021年 / 101卷

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

PT12

引用

页码：55 / 56

页数：2

共 50 条

[11] EFFICACY OF CRISABOROLE IN PATIENTS WITH MILD-TO-MODERATE ATOPIC DERMATITIS WITH AND WITHOUT FOOD ALLERGIES
Blaiss, M.
Cork, M.
Lio, P.
Kessel, A.
Takiya, L.
Werth, J.
O'Connell, M.
Zang, C.
Spergel, J.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (05) : S40 - S41
[12] Efficacy Trends With Continuous Long-Term Use of Crisaborole in Patients With Mild-to-Moderate Atopic Dermatitis (AD)
Lebwohl, Mark
Hebert, Adelaide
Takiya, Liza
Miller, Lauren
Werth, John
Zang, Chuanbo
Sanders, Paul
Geng, Bob
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 145 (02) : AB190 - AB190
[13] EFFICACY OF CRISABOROLE IN PATIENTS WITH MILD-TO-MODERATE ATOPIC DERMATITIS WITH AND WITHOUT COMORBID ALLERGIC RHINITIS
Spergel, J.
Blaiss, M.
Lio, P.
Kessel, A.
Takiya, L.
Werth, J.
O'Connell, M.
Zang, C.
Cork, M.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (05) : S46 - S46
[14] Efficacy and safety of crisaborole ointment in Chinese and Japanese patients aged=2 years with mild-to-moderate atopic dermatitis
Ma, Lin
Zhang, Litao
Kobayashi, Michiko
Tao, Xiaohua
Qian, Qiufang
Cheng, Hao
Liu, Sujun
Zhou, Yangmei
Chen, Yayuan
Zhang, Jianzhong
JOURNAL OF DERMATOLOGY, 2023, 50 (07): : 847 - 855
[15] Efficacy and safety of Ruxolitinib, Crisaborole, and Tapinarof for mild-to-moderate atopic dermatitis: a Bayesian network analysis of RCTs
Cao, Xue-chen
Lu, Jia-wei
Feng, Yi-fei
Song, Le-bin
Lu, Yan
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024, 397 (07) : 4657 - 4662
[16] Impact of Crisaborole on Sleep Outcomes in Pediatric Patients with Mild-to-Moderate Atopic Dermatitis
Fowler, Joseph
Sugarman, Jeffrey
Sher, Lawrence
Zang, Chuanbo
Werth, John L.
Myers, Daniela E.
Graham, Daniela
Marfo, Alexander Agyei
Takiya, Liza
DERMATOLOGY AND THERAPY, 2023, 13 (04) : 951 - 960
[17] Impact of Crisaborole in Treatment-Experienced Patients With Mild-to-Moderate Atopic Dermatitis
Gold, Linda F. Stein
Tom, Wynnis L.
Shi, Vivian
Sanders, Paul
Zang, Chuanbo
Vlahos, Bonnie
Cha, Amy
DERMATITIS, 2024, 35 (01) : 84 - 91
[18] Impact of Crisaborole on Sleep Outcomes in Pediatric Patients with Mild-to-Moderate Atopic Dermatitis
Joseph Fowler
Jeffrey Sugarman
Lawrence Sher
Chuanbo Zang
John L. Werth
Daniela E. Myers
Daniela Graham
Alexander Agyei Marfo
Liza Takiya
Dermatology and Therapy, 2023, 13 : 951 - 960
[19] Efficacy and Safety of Crisaborole Ointment, 2%, for the Treatment of Mild-to-Moderate Atopic Dermatitis Across Racial and Ethnic Groups
Valerie D. Callender
Andrew F. Alexis
Linda F. Stein Gold
Mark G. Lebwohl
Amy S. Paller
Seemal R. Desai
Huaming Tan
William C. Ports
Michael A. Zielinski
Anna M. Tallman
American Journal of Clinical Dermatology, 2019, 20 : 711 - 723
[20] Efficacy and safety trends with continuous long-term use of crisaborole ointment 2% in patients with mild-to-moderate atopic dermatitis
Lebwohl, M. G.
BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 (04) : E100 - E101

← 1 2 3 4 5 →